Reset
Showing 20 of 110 academic articles

Study of serum Total Immunoglobulin E in Egyptian patients with newly diagnosed colorectal carcinoma

Wessam Eid, Fawzia Abo Ali, Sara Taha, Sara Zaki et al. • Zagazig University Medical Journal (2022)

Total immunoglobulin E (IgE) has roles in allergy and anti-parasitic immunity. Recently IgE showed a major role in cancer immune surveillance; an increased risk of solid and blood malignancies has been associated with total IgE deficiency. ...

DOAJ Open Access (DOAJ) DOI: 10.21608/zumj.2022.130517.2541

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors

Safwaan H. Khan, Safwaan H. Khan, Yeonjoo Choi, Mysore Veena et al. • Frontiers in Immunology (2025)

Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic malignancies, achieving remarkable clinical success with FDA-approved therapies targeting CD19 and BCMA. However, the extension of these successe...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2024.1489827

Lung cancer tumor immune microenvironment: analyzing immune escape mechanisms and exploring emerging therapeutic targets

Zhen Wang, Honglei Guo, Yanqi Song, Aidi Wang et al. • Frontiers in Immunology (2025)

Lung cancer is the most common malignant tumor in the world. Presently, there are still problems, including a high recurrence rate, resistance, and serious toxic side effects, even if conventional treatments like chemotherapy, radiotherapy,...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2025.1597686

Linker-specific monoclonal antibodies present a simple and reliable detection method for scFv-based CARNK cells

Katharina Schindler, Katharina Eva Ruppel, Claudia Müller, Ulrike Koehl et al. • Molecular Therapy: Methods & Clinical Development (2024)

Chimeric antigen receptor (CAR) T cell therapies have demonstrated significant successes in treating cancer. Currently, there are six approved CAR T cell products available on the market that target different malignancies of the B cell line...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.omtm.2024.101328

Characterization of Primate Antibody Responses to Administered Murine Monoclonal Immunoglobulin

D.E. Milenic, B. Detrick, J.C. Reynolds, D. Colcher • The International Journal of Biological Markers (1990)

Murine monoclonal antibodies (MAb) are currently being assessed for their utility as tools in cancer management. Anti-murine immunoglobulin responses have been observed in many patients receiving monoclonal antibody treatment. In this study...

DOAJ Open Access (DOAJ) DOI: 10.1177/172460089000500403

Cancer Immunology

Olivera J. Finn • New England Journal of Medicine (2008)

This review is a comprehensive account of the current status of tumor immunology, beginning with the identification of human tumor antigens and ending with a summary of clinical applications of what we know about the immunology of tumors....

OPENALEX DOI: https://doi.org/10.1056/nejmra072739

Nanomedicine for Glioblastoma: Cutting-Edge Advances and Persistent Challenges

Ladi Alik Kumar, K Sunand, Jitendra Debata, Gopal Krishna Padhy et al. • Journal of Bio-X Research (2025)

Cancer is a disorder characterized by the abnormal growth of cells that increases uncontrollably over an extended period of time. Treating cancerous brain tumors remains among the most challenging tasks for researchers, as brain tumors are ...

DOAJ Open Access (DOAJ) DOI: 10.34133/jbioxresearch.0065

Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer

Sanjay Mishra, Manish Charan, Ajeet Kumar Verma, Bhuvaneswari Ramaswamy et al. • Frontiers in Cell and Developmental Biology (2021)

Recent studies revealed that ethnic differences in mechanistic target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK-1/2) signaling pathways might be associated with the development and progression of different human mal...

DOAJ Open Access (DOAJ) DOI: 10.3389/fcell.2021.601929

A New Strategy for Efficient Screening and Identification of Monoclonal Antibodies against Oncogenic Avian Herpesvirus Utilizing CRISPR/Cas9-Based Gene-Editing Technology

Man Teng, Zi-Yu Zhou, Yongxiu Yao, Venugopal Nair et al. • Viruses (2022)

Marek’s disease virus (MDV) is an important oncogenic α-herpesvirus that induces Marek’s disease (MD), characterized by severe immunosuppression and rapid-onset T-cell lymphomas in its natural chicken hosts. Historically, MD is regarded as ...

DOAJ Open Access (DOAJ) DOI: 10.3390/v14092045

Heme iron amplifies azoxymethane initiating effect on rat colon preneoplastic lesions

Julia Keller, Pascale Plaisancié, Edwin Fouché, Edwige-Marie Pralet et al. • Redox Experimental Medicine (2025)

Objective: Colorectal cancer is a major public health issue for which dietary factors such as red and processed meat consumption seem to play a prominent role. Heme iron, which is present in important concentration in those food products, w...

DOAJ Open Access (DOAJ) DOI: 10.1530/REM-25-0001

Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances

Angel Chao, Ren-Chin Wu, Chiao-Yun Lin, Ting-Chang Chang et al. • Biomedical Journal (2023)

Small cell neuroendocrine carcinoma of the cervix (SCNECC) is an uncommon but aggressive uterine malignancy, the cause of which is generally associated with human papillomavirus (HPV) infection. A lack of clinical trials and evidence-based ...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.bj.2023.100633

Integrating NLP to Enhance Algorithmic Identification of Metastatic and Castration‐Resistant Prostate Cancer in Large Claims‐Based Studies

Shannon R. Stock, Joshua A. Parrish, Michael T. Burns, Jessica L. Janes et al. • Cancer Medicine (2025)

ABSTRACT Purpose Accurate classification of prostate cancer (PC) disease states defined by the presence or absence of metastasis and castration resistance (CRPC) is critical but challenging in population‐based research. As chart review is n...

DOAJ Open Access (DOAJ) DOI: 10.1002/cam4.71406

Computer vision and machine‐learning techniques for quantification and predictive modeling of intracellular anticancer drug delivery by nanocarriers

Sanjay Goswami, Kshama D. Dhobale, Ravindra D. Wavhale, Barnali Goswami et al. • Applied AI Letters (2022)

Abstract The field of cancer nanomedicine has made significant progress, but its clinical translation is impeded by many challenges, such as the difficulty in analyzing intracellular anticancer drug release by the nanocarriers due to the la...

DOAJ Open Access (DOAJ) DOI: 10.1002/ail2.50

Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics

Ji Su Hwang, Seok Gi Kim, Tae Hwan Shin, Yong Eun Jang et al. • Pharmaceutics (2022)

Cancer is a group of diseases causing abnormal cell growth, altering the genome, and invading or spreading to other parts of the body. Among therapeutic peptide drugs, anticancer peptides (ACPs) have been considered to target and kill cance...

DOAJ Open Access (DOAJ) DOI: 10.3390/pharmaceutics14050997